논문KCI 등재
A Case of Organizing Pneumonia Associated with Rituximab
1
조회
0
다운로드
1
인용
0
참고문헌
주제분류의학일반
초록
Abstract
Rituximab is a human/murine chimeric anti-CD20 mono- clonal antibody used to treat CD20-positive B-cell non- Hodgkin’s lymphoma (NHL). Although most of the adverse effects associated with rituximab are usually reversible and temporary infusion-related reactions, including fever, chills, flushing and skin reactions, there are several reports of pulmonary events after long-term administration of rituximab. We present a case of asymptomatic nodular organizing pneumonia occurring during rituximab-based chemotherapy in a patient with non- Hodgkin’s lymphoma. (Cancer Res Treat. 2005;37:88- 91)
참고문헌 (15)
- Coiffier B, "CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B cell lymphoma", 346, pp.235~242 (2002)
- Feugier P, "Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte", 23, pp.4117~4126 (2005)
- Sehn LH, "Rapid infusion rituximab in combination with corticosteroid containing chemotherapy or as maintenance therapy is well tolerated and can safely be delivered in the community setting", 109, pp.4171~4173 (2007)
- Mohrbacher A, "B cell non-Hodgkin's lymphoma: rituximab safety experience", 7(3), pp.19~25 (2005)
- Biehn SE, "Bronchiolitis obliterans with organizing pneumonia after rituximab therapy for non-Hodgkin's lymphoma", 24, pp.234~237 (2006)
- Macartney C, "Bronchiolitis obliterans organizing pneumonia in a patient with non-Hodgkin's lymphoma following R-CHOP and pegylated filgrastim", 46, pp.1523~1526 (2005)
- Leon RJ, "Rituximab- induced acute pulmonary fibrosis", 79, pp.949~9953 (2004)
- Mian M, "Extensive organizing pneumonia during chemo-immunotherapy containing rituximab and G-CSF in a patient with diffuse large B-cell lymphoma: case report and review of the literature", 47, pp.1683~1685 (2006)
- Burton C, "Interstitial pneumonitis related to rituximab therapy", 348, pp.2690~2691 (2003)
- Brusamolino E, "Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity", 91, pp.496~502 (2006)
- Cordier JF, "Cryptogenic organizing pneumonia", 25, pp.727~738 (2004)
- Astudillo L, "Solitary nodular form of bronchiolitis obliterans organizing pneumonia", 117, pp.887~888 (2004)
- Epler GR., "Bronchiolitis obliterans organizing pneumonia", 161, pp.158~164 (2001)
- Alexandrescu DT, "Fatal intra-alveolar hemorrhage after rituximab in a patient with non-Hodgkin lymphoma", 45, pp.2321~2325 (2004)
- Cordier JF, "Brune J. Idiopathic bronchiolitis obliterans organizing pneumonia. Definition of characteristic clinical profiles in a series of 16 patients. Chest. 1989;96", pp.999~1004
이 간행물의 다른 논문 (7건)
Phase II Study of Docetaxel and Cisplatin as First-line Chemotherapy in Patients with Recurrent or Metastatic Gastric CancerKi-Ju Jeung, Hyun-Jung Kim, 박성규, Jong-Ho Won, Kyung-Ha Kim, Hee-Sook Park, Dae-Sik Hong, Kyu-Taek Lee, Nam-Su Lee, Chan-Kyu Kim, Sang-Byung Baepp. 49-53Autologous Stem Cell Transplantation using a Modified TAM Conditioning Regimen for Clinically Aggressive Non-Hodgkin’s LymphomaMyung Ah Lee, Chun Choo Kim, Woo Sung Min, Ji Chan Park, Ji Yean Peak, Sang Young Rho, Yoon Ho Koh, Sook Hee Hong, Young Seon Hong, In Sook Woo, Jae Ho Byun, Byoung Yong Shim, 이종욱pp. 54-60Differences in Overall Survival When Colorectal Cancer Patients are Stratified into New TNM Staging StrategyHearn-Kook Kim, Hyoung-Jung Chung, Ho-Suk Oh, Jong-Soo Choipp. 61-64Clinical Characteristics of Primary Peritoneal CarcinomaIn Sook Woo, Jae Ho Byun, Byoung Yong Shim, Myung Ah Lee, Yoon Ho Ko, Sook Hee Hong, Sang Young Roh, Kyung Shik Lee, 강진형, Tae Hee Kim, Young Seon Hongpp. 65-68Detection of Lung Cancer using MAGE A1-6 and SSX4 RT-PCR Expression Profiles in the Bronchial Wash FluidKwan-Ho Lee, 전창호, Kyung-Chul Shin, Chae-Hun Lee, Sang-Hoon Jheonpp. 69-73